Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer

THURSDAY, Jan. 23, 2025-- For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) leads to improved survival compared with preoperative chemoradiotherapy...